[Expressions of Bim and ERKs in multidrug-resistant hepatic carcinoma cells]

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Dec;34(12):1838-41.
[Article in Chinese]

Abstract

Objective: To investigate the expressions of extracellular signal-regulated kinase (ERK) and the BH3-only subgroup of Bcl-2 related proteins (Bim) in multidrug-resistant hepatocellular carcinoma (HCC) cells and their association with drug resistance in the cells.

Methods: The multdrug-resistant HepG-2 cell line was established by treatment with gradually increasing doses of ADM. CCK-8 assay was used to determine the drug sensitivity of the cells, and the expressions of MRP-1, P-gp, ERK1, ERK2, ERK5, and Bim were detected with Western blot. Bim mRNA expression level was measured using quantitative real-time PCR.

Results: The drug resistance indices to ADM, 5-FU and CDDP was 6.8, 4.10, and 4.5 in HepG-2/ADM cells, respectively. The drug-resistantcells showed marked up-regulation of MRP-1, P-gp, ERK1, ERK2 and ERK5 with down-regulated phosphorylated ERK2 protein expression but no significant changes in phosphorylated ERK1 protein expression to result in a decreased ratio of P-ERK1/2 and P-ERK1/2. Bim mRNA and protein expressions were both decreased in HepG-2/ADM cells.

Conclusion: ERK and Bim are related to multidrug resistance in HepG-2/ADM cells.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Carcinoma, Hepatocellular / metabolism*
  • Down-Regulation
  • Drug Resistance, Multiple*
  • Drug Resistance, Neoplasm*
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms / metabolism*
  • Phosphorylation
  • Up-Regulation

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Extracellular Signal-Regulated MAP Kinases